These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 26351029)

  • 21. Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.
    Steven S; Oelze M; Brandt M; Ullmann E; Kröller-Schön S; Heeren T; Tran LP; Daub S; Dib M; Stalleicken D; Wenzel P; Münzel T; Daiber A
    Oxid Med Cell Longev; 2017; 2017():4353462. PubMed ID: 28337251
    [No Abstract]   [Full Text] [Related]  

  • 22. [Atherosclerosis progression and standard in coronary disease. Nitrate with special talents: PETN (pentaerythritol tetranitrate) is vasoprotective].
    MMW Fortschr Med; 2002 Nov; 144(45):51. PubMed ID: 12534064
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapy with pentaerithrityltetranitrate (PETN). Established effectiveness, once again on trial].
    MMW Fortschr Med; 2011 Feb; 153(7):44-5. PubMed ID: 21648143
    [No Abstract]   [Full Text] [Related]  

  • 24. Heme oxygenase-1: a novel key player in the development of tolerance in response to organic nitrates.
    Wenzel P; Oelze M; Coldewey M; Hortmann M; Seeling A; Hink U; Mollnau H; Stalleicken D; Weiner H; Lehmann J; Li H; Förstermann U; Münzel T; Daiber A
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1729-35. PubMed ID: 17541025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Options of NO substitution: proven and future methods. A pharmaceutical classic on the upswing].
    MMW Fortschr Med; 2011 Jun; 153(24-25):50-1. PubMed ID: 21717713
    [No Abstract]   [Full Text] [Related]  

  • 27. Mitochondrial oxidative stress and nitrate tolerance--comparison of nitroglycerin and pentaerithrityl tetranitrate in Mn-SOD+/- mice.
    Mollnau H; Wenzel P; Oelze M; Treiber N; Pautz A; Schulz E; Schuhmacher S; Reifenberg K; Stalleicken D; Scharffetter-Kochanek K; Kleinert H; Münzel T; Daiber A
    BMC Cardiovasc Disord; 2006 Nov; 6():44. PubMed ID: 17092343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The biotransformation of pentaerythritol tetranitrate as related to host defense reactions.
    DiCarlo FJ
    J Reticuloendothel Soc; 1967 May; 4(2):190-210. PubMed ID: 4964435
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of lisinopril on cardiac remodeling in patients with cardiosclerosis after myocardial infarction and signs of chronic heart failure].
    Blagodar VN; Petriĭ VV; Makolkin VI
    Kardiologiia; 2003; 43(9):17-20. PubMed ID: 14682288
    [No Abstract]   [Full Text] [Related]  

  • 30. The nitric oxide donor pentaerythritol tetranitrate reduces platelet activation in congestive heart failure.
    Flierl U; Fraccarollo D; Widder JD; Micka J; Neuser J; Bauersachs J; Schäfer A
    PLoS One; 2015; 10(4):e0123621. PubMed ID: 25928879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Coronary therapy in geriatrics].
    Grübl M; Klein K; Siedek H
    Wien Med Wochenschr; 1973 Dec; 123(50):741-5. PubMed ID: 4763134
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of oxidative stress in heart failure].
    Gál R; Halmosi R
    Orv Hetil; 2015 Nov; 156(47):1916-20. PubMed ID: 26568107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy of using vasodilating preparations in latent heart failure in patients with chronic ischemic heart disease].
    Volkov VS; Bratoliubov VP
    Kardiologiia; 1984 Aug; 24(8):89-92. PubMed ID: 6436573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.
    Oelze M; Schuhmacher S; Daiber A
    Exp Diabetes Res; 2010; 2010():213176. PubMed ID: 21234399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of pentaerythritol tetranitrate, amyl nitrite and alcohol on arterial blood supply to ischemic myocardium.
    LEIGHNINGER DS; RUEGER R; BECK CS
    Am J Cardiol; 1961 Apr; 7():533-7. PubMed ID: 13760550
    [No Abstract]   [Full Text] [Related]  

  • 36. Bronchodilator action of pentaerythrityl tetranitrate in experimental pulmonary embolism.
    Aviado DM; Samanek M; Palecek F; Bellet S
    Cardiologia (Basel); 1968; 52(6):340-61. PubMed ID: 4181570
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pentaerythritol tetranitrate effects on electrocardiographic changes induced by glucose loading].
    Ferlito S; Bonaventura S
    Policlinico Med; 1971; 78(6):252-62. PubMed ID: 5157399
    [No Abstract]   [Full Text] [Related]  

  • 38. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 39. [How is antianginal therapy with pentaerythritol tetranitrate executed?].
    Schneider CA
    Dtsch Med Wochenschr; 2002 Nov; 127(46):2465. PubMed ID: 12432490
    [No Abstract]   [Full Text] [Related]  

  • 40. [Latent and exertion cardiac insufficiency--an indication for nitrates].
    Olthoff KH; Wustmann U
    Z Gesamte Inn Med; 1981 Sep; 36(18):644-9. PubMed ID: 7314746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.